Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Whole blood samples from 10 MS patients were collected by standard venipuncture in lithium heparin tubes.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients

Study design awaiting verification · Frontiers in Immunology · 2019

Original publication title

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients

Juan Navarro-Barriuso; María José Mansilla; Bibiana Quirant-Sánchez; Alicia Ardiaca-Martínez; Aina Teniente-Serra; Silvia Presas-Rodríguez; Anja ten Brinke; Cristina Ramo-Tello; Eva M. Martínez-Cáceres

Copyright © 2019 Navarro-Barriuso, Mansilla, Quirant-Sánchez, Ardiaca-Martínez, Teniente-Serra, Presas-Rodríguez, ten Brinke, Ramo-Tello and Martínez-Cáceres.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The administration of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases, such as multiple sclerosis (MS). Specifically, the use of vitamin D3 for the generation of tolDC (vitD3-tolDC) constitutes one of the most widely studied approaches, as it has evidenced significant immune regulatory properties, both in vitro and in vivo. In this article, we generated human vitD3-tolDC from monocytes from healthy donors and MS patients, characterized in both cases by a semi-mature phenotype, secretion of IL-10 and inhibition of allogeneic lymphocyte proliferation.

Additionally, we studied their transcriptomic profile and selected a number of differentially expressed genes compared to control mature and immature dendritic cells for their analysis. Among them, qPCR results validated CYP24A1, MAP7 and MUCL1 genes as biomarkers of vitD3-tolDC in both healthy donors and MS patients. Furthermore, we constructed a network of protein interactions based on the literature, which manifested that MAP7 and MUCL1 genes are both closely connected between them and involved in immune-related functions. In conclusion, this study evidences that MAP7 and MUCL1 constitute robust and potentially functional biomarkers of the generation of vitD3-tolDC, opening the window for their use as quality controls in clinical trials for MS.

Authors’ abstract

The administration of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases, such as multiple sclerosis (MS). Specifically, the use of vitamin D3 for the generation of tolDC (vitD3-tolDC) constitutes one of the most widely studied approaches, as it has evidenced significant immune regulatory properties, both in vitro and in vivo. In this article, we generated human vitD3-tolDC from monocytes from healthy donors and MS patients, characterized in both cases by a semi-mature phenotype, secretion of IL-10 and inhibition of allogeneic lymphocyte proliferation.

Additionally, we studied their transcriptomic profile and selected a number of differentially expressed genes compared to control mature and immature dendritic cells for their analysis. Among them, qPCR results validated CYP24A1, MAP7 and MUCL1 genes as biomarkers of vitD3-tolDC in both healthy donors and MS patients. Furthermore, we constructed a network of protein interactions based on the literature, which manifested that MAP7 and MUCL1 genes are both closely connected between them and involved in immune-related functions. In conclusion, this study evidences that MAP7 and MUCL1 constitute robust and potentially functional biomarkers of the generation of vitD3-tolDC, opening the window for their use as quality controls in clinical trials for MS.

Publication and source details

Original title: MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients

Juan Navarro-Barriuso; María José Mansilla; Bibiana Quirant-Sánchez; Alicia Ardiaca-Martínez; Aina Teniente-Serra; Silvia Presas-Rodríguez; Anja ten Brinke; Cristina Ramo-Tello; Eva M. Martínez-Cáceres

Frontiers in Immunology · 2019

Edited by: Piotr Trzonkowski, Medical University of Gdansk, Poland

Reviewed by: Aurelie Moreau, Institut National de la Santé et de la Recherche Médicale (INSERM), France; Claudia Volpi, University of Perugia, Italy

*Correspondence: Eva M. Martínez-Cáceres emmartinez.germanstrias@gencat.cat

This article was submitted to Immunological Tolerance and Regulation, a section of the journal Frontiers in Immunology

Copyright © 2019 Navarro-Barriuso, Mansilla, Quirant-Sánchez, Ardiaca-Martínez, Teniente-Serra, Presas-Rodríguez, ten Brinke, Ramo-Tello and Martínez-Cáceres.2019Navarro-Barriuso, Mansilla, Quirant-Sánchez, Ardiaca-Martínez, Teniente-Serra, Presas-Rodríguez, ten Brinke, Ramo-Tello and Martínez-Cácereshttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Instituto de Salud Carlos III10.13039/501100004587PI14/01175PI16/01737PI17/01521Agentschap voor Innovatie door Wetenschap en Technologie10.13039/501100003132140191Agència de Gestió d'Ajuts Universitaris i de Recerca10.13039/501100003030FI-DGR 2015Generalitat de Catalunya10.13039/5011000028092017 SGR 103European Cooperation in Science and Technology10.13039/501100000921BM1305

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T16:48:21.479479+00:00

DOI: 10.3389/fimmu.2019.01251 · PMC6598738